![Jeffrey James Roix](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey James Roix
Algemeen Directeur bij
Stingray Bio Ltd.
Profiel
Jeffrey James Roix currently works at Stingray Bio Ltd., as Chief Executive Officer, Opal Therapeutics Ltd., as Director from 2021, and o2h Ltd, as Venture Partner from 2020.
Mr. Roix also formerly worked at NeoPhore Ltd., as Chief Executive Officer & Director and PhoreMost Ltd., as Chief Operating Officer from 2015 to 2018.
Mr. Roix received his undergraduate degree from Harvard Extension School.
Actieve functies van Jeffrey James Roix
| Bedrijven | Functie | Begin |
|---|---|---|
Stingray Bio Ltd.
 Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services | Algemeen Directeur | - |
o2h Ltd
 o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 01-07-2020 |
Opal Therapeutics Ltd.
 Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer | Directeur/Bestuurslid | 01-03-2021 |
Eerdere bekende functies van Jeffrey James Roix
| Bedrijven | Functie | Einde |
|---|---|---|
PhoreMost Ltd.
 PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Operationeel Directeur | 01-04-2018 |
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Algemeen Directeur | - |
Opleiding van Jeffrey James Roix
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Harvard Extension School
 Harvard Extension School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Finance |
Opal Therapeutics Ltd.
Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer | Health Technology |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Commercial Services |
Stingray Bio Ltd.
Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services | Commercial Services |
